Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects With PGTC Seizures

NCT03678753 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT03678753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03678753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects With PGTC Seizures
Lead sponsor
SK Life Science, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 3, 2018
Completion date
May 26, 2025
Enrollment
169 (actual)
Sites
116

Conditions

As the registry lists them; a condition with its own page is linked.

primary generalized epilepsy